Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuji Mishima

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancer Epidemiology|February 10, 2022
Epidemiological analysis of lung and mediastinal neuroendocrine neoplasms in Japan based on the national databaseShunichiro Matsuoka, Tomonobu Koizumi, Kengo Otsuki, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|November 9, 2025
Prognostic Impact of Cardiovascular Injuries for Patients with Respiratory Isolated Chest TraumaShuji Mishima, Kimihiro Shimizu, Hitoshi Igai, et al.
Journal of Thoracic Disease|September 15, 2025
Trends in isolated chest trauma in Japan: a 15-year analysis using the Japan Trauma Data BankHitoshi Igai, Kimihiro Shimizu, Shuji Mishima, et al.
JTCVS Techniques|June 20, 2024
Improving intraoperative diagnosis of spread through air spaces: A cryo-embedding-medium inflation method for frozen section analysisTakashi Eguchi, Shunichiro Matsuoka, Mai Iwaya, et al.
Cancer Science|April 21, 2026
Bispecific Ligand-Based EphB4 CAR-T Cells Generated Using Ephrin-B2 Show Potent Antitumor Activity Against Lung AdenocarcinomaHirotaka Kumeda, Koichi Hirabayashi, Shuji Mishima, et al.
JTO Clinical and Research Reports|September 24, 2025
Shedding Phosphorylated Axl Receptor in Lung Adenocarcinoma: Dual-Domain Immunohistochemistry ApproachShuji Mishima, Takashi Eguchi, Yoshinori Sato, et al.
Thoracic Cancer|October 4, 2022
Is using a consolidation tumor ratio 0.5 as criterion feasible in daily practice? Evaluation of interobserver measurement variability of consolidation tumor ratio of lung cancer less than 3 cm in sizeSachie Koike, Kimihiro Shimizu, Shogo Ide, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer Epidemiology|February 10, 2022
Epidemiological analysis of lung and mediastinal neuroendocrine neoplasms in Japan based on the national databaseShunichiro Matsuoka, Tomonobu Koizumi, Kengo Otsuki, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|November 9, 2025
Prognostic Impact of Cardiovascular Injuries for Patients with Respiratory Isolated Chest TraumaShuji Mishima, Kimihiro Shimizu, Hitoshi Igai, et al.
Journal of Thoracic Disease|September 15, 2025
Trends in isolated chest trauma in Japan: a 15-year analysis using the Japan Trauma Data BankHitoshi Igai, Kimihiro Shimizu, Shuji Mishima, et al.
JTCVS Techniques|June 20, 2024
Improving intraoperative diagnosis of spread through air spaces: A cryo-embedding-medium inflation method for frozen section analysisTakashi Eguchi, Shunichiro Matsuoka, Mai Iwaya, et al.
Cancer Science|April 21, 2026
Bispecific Ligand-Based EphB4 CAR-T Cells Generated Using Ephrin-B2 Show Potent Antitumor Activity Against Lung AdenocarcinomaHirotaka Kumeda, Koichi Hirabayashi, Shuji Mishima, et al.
JTO Clinical and Research Reports|September 24, 2025
Shedding Phosphorylated Axl Receptor in Lung Adenocarcinoma: Dual-Domain Immunohistochemistry ApproachShuji Mishima, Takashi Eguchi, Yoshinori Sato, et al.
Thoracic Cancer|October 4, 2022
Is using a consolidation tumor ratio 0.5 as criterion feasible in daily practice? Evaluation of interobserver measurement variability of consolidation tumor ratio of lung cancer less than 3 cm in sizeSachie Koike, Kimihiro Shimizu, Shogo Ide, et al.
Pageof 3